Skip to main content
Intercure Ltd. logo

Intercure Ltd. — Investor Relations & Filings

Ticker · INCR ISIN · IL0011063760 LEI · 549300KI5ESXF8F5GP06 TA Manufacturing
Open in API
Filings indexed 334 across all filing types
Latest filing 2021-09-02 Report Publication Anno…
Country IL Israel
Listing TA INCR

About Intercure Ltd.

https://www.intercure.co

Intercure Ltd. is a company focused on the production and distribution of pharmaceutical-grade medical cannabis and cannabis-based products. Operating primarily through its wholly-owned subsidiary, Canndoc Ltd., the company is a licensed producer of Good Manufacturing Practice (GMP) certified medical cannabis. Intercure's strategy involves international expansion through strategic partnerships, such as producing and distributing established brands like Cookies in European markets, and through acquisitions to access premium technologies and brands. The company leverages its EU-GMP certified manufacturing facilities to supply its products for medical use across its operational territories.

Recent filings

Filing Released Lang Actions
Continuing its Medical Cannabis Consolidation Strategy, Announces Strategic Acquisition of Cannomed Pharmacy Chain
Report Publication Announcement Classification · 1% confidence The document is very short (1811 characters) and explicitly states, "Attached hereto is a report on *Medical_Cannabis_Market_isa.pdf*". This structure—a brief filing announcing the availability of an attached or linked report—fits the definition of a Report Publication Announcement (RPA) according to the 'MENU VS MEAL' rule. It is not the full report itself (like 10-K or IR). The filing is made to the Israel Securities Authority and Tel Aviv Stock Exchange, indicating a regulatory context, but the specific action described is the publication announcement.
2021-09-02 English
Foreign Filer Report 2021
Foreign Filer Report
2021-09-01 English
Commences Trading on NASDAQ Under the Symbol “INCR”
Regulatory Filings Classification · 1% confidence The document is a press release announcing that InterCure Ltd. commenced trading on NASDAQ under the symbol "INCR" on September 1, 2021. It highlights investment points, recent financial performance (Q2 '21 revenue growth, EBITDA margin), and provides company background. This type of announcement, which communicates key operational and financial highlights immediately following a significant event (like a major listing), is characteristic of an Earnings Release (ER) or a general corporate announcement. Since it contains specific financial metrics (revenue growth, EBITDA margin) and is structured as a news release rather than a formal regulatory filing like a 10-K or IR, the best fit among the provided options is 'Earnings Release' (ER), as it serves as the initial public disclosure of recent performance context alongside the listing news. It is not a full report (10-K, IR), a transcript (CT), or a proxy statement (DEF 14A/PSI).
2021-09-01 English
Commences Trading on NASDAQ Under the Symbol “INCR”
Report Publication Announcement Classification · 1% confidence The document is a very short filing (1893 characters) originating from the Israel Securities Authority and the Tel Aviv Stock Exchange. It is titled 'Immediate Report' under Regulation 4 for a 'Foreign Corporation'. Crucially, the text states: 'Attached hereto is a report on *InterCure Commences Trading on NASDAQ Under the Symbol �INCR�* *InterCure_Nasdaq_PR_isa.pdf*'. This structure—a brief announcement stating that a primary report (in this case, a press release/report about commencing NASDAQ trading) is attached or referenced—fits the definition of a Report Publication Announcement (RPA) according to the 'MENU VS MEAL' rule. It is not the full report itself, but the notification of its availability.
2021-09-01 English
Regulatory Filings 2021
Regulatory Filings
2021-08-31 English
20F CERT
Regulatory Filings
2021-08-28 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.